LOVASTATIN (MEVINOLIN) IN THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - A MULTICENTER STUDY

被引：238

作者：

HAVEL, RJ

HUNNINGHAKE, DB

ILLINGWORTH, DR

LEES, RS

STEIN, EA

TOBERT, JA

BACON, SR

BOLOGNESE, JA

FROST, PH

LAMKIN, GE

LEES, AM

LEON, AS

GARDNER, K

JOHNSON, G

MELLIES, MJ

RHYMER, PA

TUN, P

机构：

[1] MERCK SHARP & DOHME RES LABS, DEPT CLIN RES, RAHWAY, NJ 07065 USA

[2] UNIV CALIF SAN FRANCISCO, SCH MED, CARDIOVASC RES INST, SAN FRANCISCO, CA 94143 USA

[3] UNIV MINNESOTA, LIPID RES CLIN, MINNEAPOLIS, MN 55455 USA

[4] OREGON HLTH SCI UNIV, DEPT MED, CLIN NUTR & LIPID METAB CLIN, PORTLAND, OR 97201 USA

[5] NEW ENGLAND DEACONESS HOSP, PERIPHERAL VASC DIS SECT INTERNAL MED, BOSTON, MA 02215 USA

[6] UNIV CINCINNATI HOSP, MED CTR, DEPT PATHOL & LAB MED, CINCINNATI, OH USA

来源：

ANNALS OF INTERNAL MEDICINE | 1987年 / 107卷 / 05期

关键词：

D O I：

10.7326/0003-4819-107-5-609

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：609 / 615

页数：7

共 28 条

[1] MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT
ALBERTS, AW
CHEN, J
KURON, G
HUNT, V
HUFF, J
HOFFMAN, C
ROTHROCK, J
LOPEZ, M
JOSHUA, H
HARRIS, E
PATCHETT, A
MONAGHAN, R
CURRIE, S
STAPLEY, E
ALBERSSCHONBERG, G
HENSENS, O
HIRSHFIELD, J
HOOGSTEEN, K
LIESCH, J
SPRINGER, J
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07): : 3957 - 3961
[2] MEVINOLIN AND COLESTIPOL STIMULATE RECEPTOR-MEDIATED CLEARANCE OF LOW-DENSITY LIPOPROTEIN FROM PLASMA IN FAMILIAL HYPERCHOLESTEROLEMIA HETEROZYGOTES
BILHEIMER, DW
GRUNDY, SM
BROWN, MS
GOLDSTEIN, JL
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (13): : 4124 - 4128
[3] METABOLIC STUDIES IN FAMILIAL HYPERCHOLESTEROLEMIA - EVIDENCE FOR A GENE-DOSAGE EFFECT INVIVO
BILHEIMER, DW
STONE, NJ
GRUNDY, SM
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (02) : 524 - 533
[4] BROWN MS, 1985, PHARMACOL BASIS THER, P827
[5] SERUM AND LIPOPROTEIN APOLIPOPROTEIN-B LEVELS IN NORMAL SUBJECTS AND PATIENTS WITH HYPERLIPOPROTEINEMIA
DURRINGTON, PN
BOLTON, CH
HARTOG, M
[J]. CLINICA CHIMICA ACTA, 1978, 82 (1-2) : 151 - 160
[6] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[7] GOLDSTEIN JL, 1983, METABOLIC BASIS INHE, P672
[8] GRUNDY SM, 1985, J LIPID RES, V26, P1464
[9] LIPOPROTEIN-CHOLESTEROL DISTRIBUTIONS IN SELECTED NORTH-AMERICAN POPULATIONS - LIPID RESEARCH CLINICS PROGRAM PREVALENCE STUDY
HEISS, G
TAMIR, I
DAVIS, CE
TYROLER, HA
RIFKIND, BM
SCHONFELD, G
JACOBS, D
FRANTZ, ID
[J]. CIRCULATION, 1980, 61 (02) : 302 - 315
[10] EFFECTIVENESS OF MEVINOLIN ON PLASMA-LIPOPROTEIN CONCENTRATIONS IN TYPE-II HYPERLIPOPROTEINEMIA
HOEG, JM
MAHER, MB
ZECH, LA
BAILEY, KR
GREGG, RE
LACKNER, KJ
FOJO, SS
ANCHORS, MA
BOJANOVSKI, M
SPRECHER, DL
BREWER, HB
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (11) : 933 - 939

← 1 2 3 →